Mycronic Croissance future
Future contrôle des critères 3/6
Mycronic devrait augmenter ses bénéfices et son chiffre d'affaires de 7.6% et de 11.1% par an respectivement. Le BPA devrait croître de de 11% par an. Le rendement des capitaux propres devrait être 22.8% dans 3 ans.
Informations clés
7.6%
Taux de croissance des bénéfices
11.01%
Taux de croissance du BPA
| Electronic croissance des bénéfices | -4.1% |
| Taux de croissance des recettes | 11.1% |
| Rendement futur des capitaux propres | 22.84% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 27 Apr 2026 |
Mises à jour récentes de la croissance future
Article d’analyse • Apr 29
Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...Article d’analyse • Feb 08
Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report
Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Article d’analyse • Oct 28
Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%
Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...Recent updates
Mise à jour du récit • May 09
MYCR: Clustered Downgrades And Extended Deliveries Will Pressure Near Term Upside
The updated analyst price target for Mycronic has shifted from SEK 226.50 to SEK 260.25. Analysts cite changes in growth expectations and valuation assumptions, even as several firms have recently turned more cautious on the stock.Article d’analyse • Apr 29
Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...Mise à jour du récit • Apr 24
MYCR: Extended Delivery Timeline For New Orders Will Restrain Near-Term Upside
Analysts have raised their price target on Mycronic to SEK226.50 from SEK213.67, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Order for a customized SLX mask writer from a new customer, valued between US$27 million and US$30 million, with delivery planned in 2028.Mise à jour du récit • Apr 09
MYCR: Asian Equipment Orders And 2026 Outlook Will Support Steady Dividend Profile
Analysts have slightly adjusted their price target on Mycronic from SEK 215 to about SEK 214. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples, while keeping their overall view broadly consistent.Mise à jour du récit • Mar 26
MYCR: Asian Orders And 2026 Guidance Will Underpin Stable Dividend Outlook
Analysts are maintaining their SEK 215.0 price target for Mycronic, noting only minor adjustments to inputs such as the discount rate, long-term revenue, profit margin and future P/E assumptions that do not materially change their valuation view. What's in the News Mycronic has issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (Corporate Guidance).Mise à jour du récit • Mar 09
MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook
Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.Mise à jour du récit • Feb 22
MYCR: Asian Orders And 2026 Guidance Will Shape Balanced Outlook
Analysts now keep their SEK 215.0 price target for Mycronic broadly unchanged, with slight adjustments in the discount rate, revenue growth expectations, profit margin assumptions, and future P/E multiples shaping the latest narrative update. What's in the News Mycronic issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (company guidance).Article d’analyse • Feb 08
Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report
Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Mise à jour du récit • Feb 08
MYCR: Asian Orders And Higher Margins Will Support Bullish Outlook
Analysts have trimmed their price target on Mycronic to SEK215 from about SEK218.67, citing updated assumptions that include a slightly higher discount rate, adjusted revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Mycronic announced an annual dividend of SEK 3.25 per share, with an ex dividend date set for May 7, 2026, a record date on May 8, 2026, and a payment date on May 13, 2026 (company announcement).Mise à jour du récit • Jan 24
MYCR: Asian Orders And Cautious Margins Will Support Stable Outlook
Analysts have kept their overall price target for Mycronic unchanged at SEK 218.67, with adjustments in the discount rate, profit margin and future P/E assumptions reflecting a more cautious margin outlook, offset by support from valuation multiples. What's in the News Mycronic received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (company announcement).Article d’analyse • Jan 23
Mycronic (STO:MYCR) Is Reinvesting To Multiply In Value
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Mise à jour du récit • Jan 08
MYCR: Asian Equipment Orders And Higher Margins Will Support Steady Outlook
Analysts have left their fair value estimate for Mycronic unchanged at SEK 218.67. The latest price target is shaped mainly by slightly revised assumptions on discount rate, revenue growth, profit margin and future P/E, which together reflect a more balanced view of the company’s earnings profile and valuation risk.Article d’analyse • Dec 31
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Mycronic's estimated fair value is kr215 based on 2 Stage Free Cash Flow to Equity Current share price of...Mise à jour du récit • Dec 13
MYCR: Expanding Asian Orders Will Support Steady Earnings And Balanced Prospects
Analysts have nudged their price target for Mycronic slightly higher to approximately SEK 219 per share, reflecting modestly increased discount rate and future P E assumptions, while maintaining a generally stable view on long term revenue growth and profitability. What's in the News Mycronic secured a new Asian customer for its SLX semiconductor mask writer, an energy efficient system with an order value between USD 5 million and 7 million, with revenue recognized in the current quarter (company announcement).Mise à jour du récit • Nov 27
MYCR: Growing Asian Orders And Margins Will Support Measured Gains Through 2025
Analysts have slightly increased their price target for Mycronic to SEK 218.67 from SEK 217.33. They cite improved revenue growth expectations and a marginally higher projected profit margin.Mise à jour du récit • Nov 07
MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025
Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.Article d’analyse • Oct 28
Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%
Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...Mise à jour du récit • Oct 24
Upcoming Orders and Expansion Will Drive Global Technology Reach Forward
Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.Mise à jour du récit • Oct 10
Acquisitions And Launches Will Expand Global Technology Reach
Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.Article d’analyse • Sep 19
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Mycronic fair value estimate is kr235 With kr220 share price...Mise à jour du récit • Aug 27
Acquisitions And Launches Will Expand Global Technology Reach
The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.Article d’analyse • Aug 23
Does Mycronic (STO:MYCR) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Article d’analyse • Aug 10
Does Mycronic (STO:MYCR) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Article d’analyse • Jul 29
Mycronic (STO:MYCR) Is Achieving High Returns On Its Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Article d’analyse • Jun 27
Weekly Picks: 🪙 USA's Silver and Gold Potential, DLO's Trusted Brand, and MYCR's Tailwinds
How Americas Gold and Silver could deliver 6-10x upside over 5 years, why DLocal’s trusted brand in emerging markets is under appreciated, and why Mycronic will benefit from an electronics-complexity super-cycle.
Nouveau récit • Jun 24
Historically Cheap, but the Margin of Safety Is Still Thin
Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directlyArticle d’analyse • Jun 21
At kr180, Is It Time To Put Mycronic AB (publ) (STO:MYCR) On Your Watch List?
While Mycronic AB (publ) ( STO:MYCR ) might not have the largest market cap around , it saw significant share price...
Nouveau récit • Dec 24
Modus Acquisition And Prexision 8000 Launch Will Propel High-Tech Growth And Sustainability
Strategic acquisitions and new product launches align with industry trends, potentially boosting revenue and expanding market presence across segments.Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 10,584 | 2,057 | 2,118 | 2,415 | 3 |
| 12/31/2027 | 9,234 | 1,840 | 1,908 | 2,173 | 4 |
| 12/31/2026 | 8,651 | 1,726 | 1,697 | 1,961 | 4 |
| 3/31/2026 | 8,299 | 1,655 | 1,589 | 1,777 | N/A |
| 12/31/2025 | 7,938 | 1,560 | 1,242 | 1,407 | N/A |
| 9/30/2025 | 7,975 | 1,743 | 1,450 | 1,637 | N/A |
| 6/30/2025 | 8,046 | 1,974 | 1,229 | 1,423 | N/A |
| 3/31/2025 | 7,507 | 1,814 | 1,112 | 1,378 | N/A |
| 12/31/2024 | 7,057 | 1,683 | 1,636 | 1,874 | N/A |
| 9/30/2024 | 6,967 | 1,735 | 1,576 | 1,780 | N/A |
| 6/30/2024 | 6,461 | 1,490 | 1,680 | 1,893 | N/A |
| 3/31/2024 | 6,179 | 1,338 | 1,810 | 1,943 | N/A |
| 12/31/2023 | 5,706 | 998 | 1,416 | 1,608 | N/A |
| 9/30/2023 | 5,235 | 736 | 1,316 | 1,482 | N/A |
| 6/30/2023 | 5,175 | 685 | 1,312 | 1,441 | N/A |
| 3/31/2023 | 5,203 | 725 | 1,050 | 1,182 | N/A |
| 12/31/2022 | 5,119 | 741 | 712 | 853 | N/A |
| 9/30/2022 | 4,916 | 669 | 516 | 656 | N/A |
| 6/30/2022 | 4,688 | 597 | 416 | 562 | N/A |
| 3/31/2022 | 4,479 | 603 | 549 | 686 | N/A |
| 12/31/2021 | 4,635 | 828 | 908 | 998 | N/A |
| 9/30/2021 | 4,334 | 827 | 962 | 1,053 | N/A |
| 6/30/2021 | 4,415 | 1,012 | 1,444 | 1,541 | N/A |
| 3/31/2021 | 4,437 | 1,045 | 1,109 | 1,226 | N/A |
| 12/31/2020 | 3,882 | 694 | 991 | 1,126 | N/A |
| 9/30/2020 | 4,071 | 670 | 852 | 1,050 | N/A |
| 6/30/2020 | 3,904 | 551 | 359 | 588 | N/A |
| 3/31/2020 | 3,938 | 581 | 571 | 762 | N/A |
| 12/31/2019 | 4,307 | 855 | N/A | 545 | N/A |
| 9/30/2019 | 4,177 | 830 | N/A | 958 | N/A |
| 6/30/2019 | 4,373 | 1,031 | N/A | 964 | N/A |
| 3/31/2019 | 4,136 | 962 | N/A | 768 | N/A |
| 12/31/2018 | 3,781 | 790 | N/A | 702 | N/A |
| 9/30/2018 | 3,655 | 890 | N/A | 225 | N/A |
| 6/30/2018 | 3,049 | 586 | N/A | 587 | N/A |
| 3/31/2018 | 3,072 | 654 | N/A | 785 | N/A |
| 12/31/2017 | 3,000 | 624 | N/A | 984 | N/A |
| 9/30/2017 | 3,090 | 702 | N/A | 967 | N/A |
| 6/30/2017 | 3,096 | 773 | N/A | 576 | N/A |
| 3/31/2017 | 2,653 | 614 | N/A | 350 | N/A |
| 12/31/2016 | 2,319 | 526 | N/A | 462 | N/A |
| 9/30/2016 | 1,925 | 416 | N/A | 540 | N/A |
| 6/30/2016 | 2,033 | 529 | N/A | 712 | N/A |
| 3/31/2016 | 1,855 | 448 | N/A | 771 | N/A |
| 12/31/2015 | 1,815 | 442 | N/A | 661 | N/A |
| 9/30/2015 | 1,850 | 480 | N/A | 626 | N/A |
| 6/30/2015 | 1,583 | 282 | N/A | 549 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de MYCR ( 7.6% par an) est supérieure au taux d'épargne ( 2% ).
Bénéfices vs marché: Les bénéfices de MYCR ( 7.6% par an) devraient croître plus lentement que le marché Swedish ( 8.5% par an).
Croissance élevée des bénéfices: Les bénéfices de MYCR devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de MYCR ( 11.1% par an) devrait croître plus rapidement que le marché Swedish ( 0.02% par an).
Croissance élevée des revenus: Le chiffre d'affaires de MYCR ( 11.1% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de MYCR devrait être élevé dans 3 ans ( 22.8 %)
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/20 09:53 |
| Cours de l'action en fin de journée | 2026/05/20 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Mycronic AB (publ) est couverte par 9 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Nils Sjogren | ABG Sundal Collier Sponsored |
| Oliver Wong | BofA Global Research |
| Mikael Laséen | Carnegie Investment Bank AB |